Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Benign Thyroid Nodules Follow-Up Shows Favorable Prognosis

By LabMedica International staff writers
Posted on 24 Mar 2015
A majority of asymptomatic, benign thyroid nodules exhibited no significant change in size, after five years of follow-up, or actually decreased in size, and diagnoses of thyroid cancer were rare. More...


The discovery of a thyroid nodule may be stressful for the patient, but more than 90% of the detected nodules are clinically insignificant benign lesions. Fine-needle aspiration cytology is the procedure of choice to identify suspicious lesions that require thyroid surgery.

Scientists at the Università di Roma Sapienza (Rome, Italy) and colleagues studied the frequency, magnitude, and factors associated with changes in thyroid nodule size. The study involved 992 patients with one to four asymptomatic, sonographically or cytologically benign thyroid nodules. Patients were recruited from eight hospital-based thyroid-disease referral centers in Italy between 2006 and 2008. Data collected during the first five years of follow-up, through January 2013, were analyzed. Size changes were considered significant for growth if an increase of 20% or more was recorded in at least two nodule diameters, with a minimum increase of two mm.

Fine-needle aspiration was performed or repeated when suspicious findings such as hypoechogenicity, irregular margins, taller-than-wide shape, intranodular vascular spots, microcalcifications, developed subsequent to the baseline ultrasound examination. Thyroid function tests were also measured. Nodule growth occurred in 153 patients (15.4%) and 174 of the 1,567 original nodules (11.1%) increased in size. Nodule growth was associated with presence of multiple nodules. In 184 individuals (18.5%), nodules shrank. Thyroid cancer was diagnosed in five original nodules (0.3 %), only two of which had grown. New nodules developed in 93 patients (9.3%), with detection of one cancer.

The authors noted that one of the goals of surveillance is the prompt detection and treatment of thyroid cancers that arise during follow-up or have been missed on the initial assessment. In the population they studied, these events were rare. Only two of the five diagnoses of cancer in an established nodule were preceded by significant growth of the cancerous nodule. Among patients with asymptomatic thyroid nodules that were sonographically or cytologically benign, the majority of nodules exhibited no significant size change during five years of follow-up or they actually decreased in size. The study was published on March 3, 2015, in the Journal of the American Medical Association (JAMA).

Related Links:

Università di Roma Sapienza



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.